BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Roth S, Torregroza C, Feige K, Preckel B, Hollmann MW, Weber NC, Huhn R. Pharmacological Conditioning of the Heart: An Update on Experimental Developments and Clinical Implications. Int J Mol Sci 2021;22:2519. [PMID: 33802308 DOI: 10.3390/ijms22052519] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 4.5] [Reference Citation Analysis]
Number Citing Articles
1 Gadjieva LA, Bolevich SB, Jakovlevich V, Omarov IA, Ordashev HA, Kartashova MK. Creatine phosphate preconditioning reduces ischemiareperfusion injury in isolated rat heart. jour 2022;13:24-33. [DOI: 10.47093/2218-7332.2022.13.1.24-33] [Reference Citation Analysis]
2 Li Y, Gao Y, Li G. Preclinical multi-target strategies for myocardial ischemia-reperfusion injury. Front Cardiovasc Med 2022;9. [DOI: 10.3389/fcvm.2022.967115] [Reference Citation Analysis]
3 Vismont FI, Chepelev SN, Goubkin SV. Nitrogen monoxide participation in the mechanisms of realization of the infarction-limiting effect of post-conditioning using lactate during myocardial ischemia-reperfusion in young and old rats. Dokl Akad nauk 2022;66:206-216. [DOI: 10.29235/1561-8323-2022-66-2-206-216] [Reference Citation Analysis]
4 Penna C, Comità S, Tullio F, Alloatti G, Pagliaro P. Challenges facing the clinical translation of cardioprotection: 35 years after the discovery of ischemic preconditioning. Vascular Pharmacology 2022. [DOI: 10.1016/j.vph.2022.106995] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Feige K, Torregroza C, Gude M, Maddison P, Stroethoff M, Roth S, Lurati Buse G, Hollmann MW, Huhn R. Cardioprotective Properties of Humoral Factors Released after Remote Ischemic Preconditioning in CABG Patients with Propofol-Free Anesthesia-A Translational Approach from Bedside to Bench. J Clin Med 2022;11:1450. [PMID: 35268540 DOI: 10.3390/jcm11051450] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Ye R, Jneid H, Alam M, Uretsky BF, Atar D, Kitakaze M, Davidson SM, Yellon DM, Birnbaum Y. Do We Really Need Aspirin Loading for STEMI? Cardiovasc Drugs Ther 2022. [PMID: 35171384 DOI: 10.1007/s10557-022-07327-x] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
7 García-Niño WR, Zazueta C, Buelna-Chontal M, Silva-Palacios A. Mitochondrial Quality Control in Cardiac-Conditioning Strategies against Ischemia-Reperfusion Injury. Life (Basel) 2021;11:1123. [PMID: 34832998 DOI: 10.3390/life11111123] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
8 Torregroza C, Gnaegy L, Raupach A, Stroethoff M, Feige K, Heinen A, Hollmann MW, Huhn R. Influence of Hyperglycemia and Diabetes on Cardioprotection by Humoral Factors Released after Remote Ischemic Preconditioning (RIPC). Int J Mol Sci 2021;22:8880. [PMID: 34445586 DOI: 10.3390/ijms22168880] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]